In recent years there has been significant growth in the pharmaceutical industry of CIS countries like Azerbaijan, Uzbekistan, Moldova and Georgia. In this article, Pelin …
The road towards product development and regulatory approval is long, arduous and costly. Thus, to recoup the money invested in the drug and make it …
Regulatory activity in the life sciences world is extremely variable, so historically, attempts to measure output have been too simplistic to be effective. When the …
The European Union’s (EU) FMD regulations come into force in February 2019. Bart Vansteenkiste at Domino discusses an FMD-compliant system that combines manual and automated …
There are exciting and interesting trends emerging. Therapies once only feasible within a clinical setting are now being self-administered at home, enabled by innovations in …
As the medical device market evolves to become highly sophisticated and advanced, manufacturers face constant pressures in being able to reduce particulate in the production …
In offering the most sensitive and selective analysis, liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a cornerstone of modern pharmaceutical research. Dr Ed Connor at Peak …
The global biopharmaceuticals market accounted for $ 160 billion in 2014, and it is expected to grow with a CAGR of 9.6% during 2015 – …
Finding ways to enhance real-world evidence datasets to better understand patient outcomes is a key opportunity in real-world evidence studies. The NHS dataset known as …
Stress is your body’s way of responding to any kind of demand or threat. When you sense danger – whether it’s real or imagined – …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
